Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: a meta-analysis
2016 · BMC Cancer · 45 citations
https://doi.org/10.1186/s12885-016-2706-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
122
Citations
5
h-index
5
i10-index
Changle Shi is an academic researcher from Sichuan University. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Salivary Gland Tumors Diagnosis and Treatment & Breast Cancer Treatment Studies. The author has an h-index of 5, co-authored 6 publications.
Click to start Chat